Association for Accessible Medicines
Senior Vice President of Policy and Scientific Affairs
Christine Simmon is Senior Vice President of Policy and Scientific Affairs for the Association for Accessible Medicines (AAM). She joined the Association for Accessible Medicines in 2012 as the Senior Vice President of Policy & Strategic Affairs and most recently was named Executive Director of AAM’s Biosimilars Council, founded in 2015.
In her current role, Ms. Simmon is responsible for leading policy development and issues management for AAM, directing the Biosimilars Council, and building relationships with strategic partners in the healthcare sector, including patient advocacy groups.
Ms. Simmon had previously served as Vice President of Policy, Public Affairs & Development at AAM from 2002 to 2006. Before rejoining the association, she was the Senior Director of Public Policy for CVS Caremark, where she was the policy lead for the integrated retail, convenient care clinic and pharmacy benefit manager enterprise at both the state and federal levels. Previously, Ms. Simmon was a Senior Policy Analyst at BlueCross BlueShield Association, where she helped position the insurer as a leading voice on pharmaceutical cost and safety issues.
She received her J.D. from Georgetown University Law Center and her B.A. in American Studies from Georgetown University.